Bio Farma and MSD launch human papillomavirus vaccine in Indonesia

Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...

August 4, 2023 | Friday | News
Japan's Toyo Ink Group invests in US-based VLP Therapeutics to accelerate vaccine development

Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...

August 3, 2023 | Thursday | News
Zuellig Pharma and GSK establish vaccine distribution hub in Singapore

Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...

August 1, 2023 | Tuesday | News
“Making mRNA vaccines in Asia can potentially bring more affordable vaccines to the world”

What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...

August 2, 2023 | Wednesday | Opinion
Korea's GC Biopharma gets its first-ever approval of quadrivalent flu vaccine in Africa

GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...

July 24, 2023 | Monday | News
GSK expands its state-of-the-art vaccines facility in Singapore with a S$343 million investment

GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...

July 13, 2023 | Thursday | Company results
Sanofi to manufacture and supply vaccines in Saudi Arabia

Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...

July 6, 2023 | Thursday | News
SK bioscience to transfer technology for strengthening vaccine manufacturing in Thailand

South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...

July 6, 2023 | Thursday | News
Japan approves updated indication for GSK's Shingrix vaccine

British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...

June 28, 2023 | Wednesday | News
Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...

June 28, 2023 | Wednesday | News
International Vaccine Institute inks new agreement with Seoul National University

The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...

June 21, 2023 | Wednesday | News
Vaxxas opens manufacturing facility in Australia to produce needle-free vaccine patch

Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...

June 19, 2023 | Monday | News
Korea-Africa establish new partnership for vaccine R&D and biomanufacturing training

South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...

June 14, 2023 | Wednesday | News
mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers: Merck study

According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...

June 1, 2023 | Thursday | News
SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...

May 31, 2023 | Wednesday | News
Devising a viable global strategy to combat Cholera

For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...

May 31, 2023 | Wednesday | Opinion
Korea's International Vaccine Institute establishes Joint Research Institution in China

South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...

May 23, 2023 | Tuesday | News
China approves two COVID-19 vaccine trials against most recent circulating XBB variants

Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...

May 22, 2023 | Monday | News